Intrinsiqq
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. Quality Score

AVXL

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 28 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with AVXL

CompareIntrinsic value
CSBRChampions Oncology, Inc.
$4.35-1.14%26
CRDFCardiff Oncology Inc.
$0.85-4.18%36
VXRTVaxart Inc.
$0.33-8.33%84
WINTWindtree Therapeutics Inc.
$0.00-33.33%10
CELZCreative Medical Technology Holdings Inc.
$0.40-8.14%10
CVMCel-Sci Corporation
$1.21-17.69%0
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
PLURPluri Inc.
$0.94-3.09%30

Held by ETFs

AVXL is in 9 US ETFs. The largest of them, with AVXL's weight in each:

Spot a number that looks wrong? Check it in AVXL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AVXL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.